High-Volume Scanners

WHITE PAPERS AND CASE STUDIES

• Streamlining And Standardizing CGT From Process To Product

  Cell and gene therapies are transforming treatment, but rapid progress strains supply chains, requiring scaled manufacturing and increased capacity.

• Sulzer Submersible Aerator Mixer Improves Wastewater Treatment In A Cardboard Mill

  With the increase of a WWTP's capacity, the oxygenation of its basins had become insufficient. Learn about the upgrade of its aeration performance of the existing installation with minimal capital expenditure. 

• Proprietary Reactivation Study Demonstrates PFAS Removal And Destruction Expertise

  Thermal reactivation of granular activated carbon is a proven and scalable method to achieve >99.9% destruction removal efficiency for PFAS. This process fully restores the carbon for reuse, providing a sustainable solution that breaks the cycle of "forever chemicals."

• Key West Resort Utilities Maximizes Reuse And Nutrient Recovery

  Water scarcity poses unique challenges to KW Resort Utilities Corp. (KWRU), the utility firm that provides wastewater management, wastewater recovery, and wastewater treatment in the region. KWRU began operation in the late 1960s and has worked hard over the decades to keep up with wastewater needs as population and tourism have boomed, spurred by land reclamation and development. 

• Developing A Data Strategy For Clinical Trials

  This white paper outlines a standardized method for developing a data strategy that can be tailored to a company's current needs and adapted as those needs evolve.

• Acoustic Inspection Helps Campbell River Optimize Inspection Program

  In this case study, explore how incorporating the SL-RAT into their maintenance program has realized significant savings for the city of Campbell River.

• Exploring Perfusion Technology For Virus Manufacturing Process Intensification

  Perfusion cell culture technology supports high cell densities and product yields for viral vaccine manufacturing, offering a reliable way to produce high-quality cells at a commercial scale.

• Non-Viral Genetic Modification Using The 4D-Nucleofector LV Unit In CGT

  This paper underscores the 4D-Nucleofector® LV Unit as a pivotal tool for translating genetic modification technologies into scalable, safe, and effective therapeutic solutions.

• Catalent's Journey Of Continuous Improvement For CSV Excellence

  Learn how organizations must continuously reassess validation processes and digital tools to ensure compliance, enhance efficiency, and support global scalability amidst evolving regulatory expectations.

• A Strategic Guide For Biotech And Biopharma Leaders

  Securing drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.

• The True ROI Of Decentralized Clinical Trials

  Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.

• An Experienced CDMO Can Be A Differentiator In The Rapidly Growing Biologics Market

  Discover how an experienced CDMO offering a purpose-built facility with flexible capacity can help biopharmaceutical companies bring their products to market quickly and efficiently.